Subscribe
Call Us: 02380 97 07 33

Archive for 2012

If you can see the damage, you’ll stop!

If you can see the damage, you’ll stop!

A new ad campaign to encourage people to quit…   Make quitting an important component of your New Year resolution.   as my friend Cyril, a smoker, said himself:   No good comes from smoking.   The question is: Wouldn’t you want to stop if you could see […]

Read more

Case Study 8: Being Cyril

Case Study 8: Being Cyril

by Kazeem Olalekan MRPharmS   In our latest interview, Kazeem chats with Cyril Siou – Community Pharmacist. This interview effectively introduces the reader to Cyril – the man. He was one of the people that said yes when I presented him with a blank canvass of what […]

Read more

My Conference notes 2: What is Medicines Optimisation?

My Conference notes 2: What is Medicines Optimisation?

by Kazeem Olalekan MRPharmS I was at the Pharmacy Management National Forum held on Thursday 15 November 2013 at Novotel  in Hammersmith. This is the second instalment of my conference notes. In my first instalment, I eluded to what we are doing in  Wessex around transfer of care. I will be […]

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Read more

Case Study 7: To infinity and beyond…

Case Study 7: To infinity and beyond…

by Kazeem Olalekan MRPharmS It is with great pleasure that I introduce the subject of our most current case study. I have been busy interviewing this amazing community pharmacist.  Her name is Patricia Lee, Community Pharmacist at Tesco-in-store pharmacy at Bursledon Towers, mother to Lucas, wife to […]

Read more

My Conference notes 1: Pharmacy Management National Forum

My Conference notes 1: Pharmacy Management National Forum

by Kazeem Olalekan MRPharmS One of the cornerstones of pharmaceutical research (and indeed any other scientific research) is dissemination. If you have done the work, why would you not want people to know about it? It is with that in mind that I congratulate the Chief Pharmaceutical […]

Read more

Pharmacy: The Profession of Aspiration

Pharmacy: The Profession of Aspiration

by Kazeem Olalekan MRPharmS When I talk about Pharmacy being the profession of aspiration, some of my colleagues cringe! I understand why they might. It fits into an old narrative that goes something like this: we are pharmacists because we failed in our bid to get into […]

Read more

Vision coming together…

Vision coming together…

by Kazeem Olalekan MRPharmS I took my daughter to the optician recently and it got me thinking: What an amazing thing: vision! We all need it and all the better if it is a good one. In October last year, I wrote a blog about the 2020 […]

Read more

Apps Updates! – MicroGuide; NICE Guidance; CPPE; NICE BNF; NICE BNFc

Apps Updates! – MicroGuide; NICE Guidance; CPPE; NICE BNF; NICE BNFc

by Kazeem Olalekan MRPharmS If you follow our blog, you will know that we are passionate about apps (you know..iphone (OS), android and possibly others – I know Microsoft is working very hard to narrow the gap on its rivals – so when we get our hands […]

Read more

Who will show clinical leadership?

Who will show clinical leadership?

by Kazeem Olalekan MRPharmS I cannot help but notice, with concern, the latest news item by in which  Boots the Chemist is to offer ‘3 for 2’ mix and match promotion across its entire healthcare range this week (link). Clearly the customer will welcome an opportunity to pay […]

Read more

Did you miss any of these?

Did you miss any of these?

by Kazeem Olalekan MRPharmS In August a number of communications on medicines safety were sent out to healthcare professionals via the MHRA. If you missed any of it then here are the summary. Full details are available on the MHRA website. Number 1: Number 2: Number 3: […]

Read more

Case Study 6: Critical Evaluation

Case Study 6: Critical Evaluation

by Kazeem Olalekan MRPharmS This July we have posted our 6th Case Study. We are quite proud about this one. Kazeem conducted an interview with Sue Gough, a Critical Evaluation Pharmacist at University Hospitals Southampton NHS Foundation Trust. It provides an insight into what these breeds of […]

Read more

Saved – The future is bright.

Saved – The future is bright.

by Kazeem Olalekan MRPharmS I was delighted by the news that the National Paediatric Surgery Reviews has opted for option B which means that University Hospital Southampton NHS Foundation Trust (UHSFT) in partnership with Oxford Radcliffe Hospitals NHS Trust will continue to deliver first class quality service […]

Read more

New MUR Requirements

New MUR Requirements

by Kazeem Olalekan MRPharmS     The latest update to MUR requirements (1) which applied from the 1st of July is refreshing. If I was commissioning the service for the first time, this is what it might look like. Nonetheless, evolution is not a bad thing. The […]

Read more

Yet another one from the nice folks at NICE – NICE BNF

Yet another one from the nice folks at NICE – NICE BNF

by Kazeem Olalekan Clearly I am excitable. When I learnt of the new iphone and Android app from the nice folks at NICE, then you know what is coming. Hee Heee Heeeeeeeeeeeeeeeeeeeeee  Haaaaaaaaaaaah! I’ll tell you why. I spent my top dollar about a year ago on […]

Read more

Febuxostat (Adenuric) and hypersensitivity reaction

Febuxostat (Adenuric) and hypersensitivity reaction

by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately […]

Read more
Page 1 of 41234

Disclaimer

The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.